In human metastatic bladder cancer, tumor cells overexpress the enzyme 2β-1,6-N-acetylglucosaminyltransferase (C2GnT) that adds a poly-N-acetyllactosamine on Mucin-1. This evidence concerns the gene MUC1 and neoplasm.